Keith L Brownlie
CIK 1518575 · last filed 2025-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
7
Total Filings
29
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLDX | Director | — | $31.27 | — | $0 | 7 | 2025-06-09 |
| Phio Pharmaceuticals Corp. (PHIOW) Delisted | Director | 20,000 | $0.02 | $464 | $0 | 1 | 2019-02-15 |
| SOLIGENIX, INC. (SNGXW) Delisted | Director | — | $0.01 | — | $0 | 2 | 2018-09-28 |
| Phio Pharmaceuticals Corp. (RXIIW) Delisted | Director | 10,000 | — | — | $0 | 2 | 2018-08-03 |
| Phio Pharmaceuticals Corp. (RXII) Delisted | Director | — | — | — | $0 | 2 | 2016-02-12 |
| Vyant Bio, Inc. (CGIX) Delisted | Director | — | $4.61 | — | $0 | 1 | 2013-10-15 |
| IMMUNE PHARMACEUTICALS INC (EPCT) Delisted | Director | — | — | — | $0 | 2 | 2011-06-16 |
Recent Filings · Page 2 of 3
29 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-15 | — | Grant (A) | — | $0 | |
| 2017-06-16 | — | Grant (A) | +10,000 | $0 | |
| 2017-06-12 | SOLIGENIX, INC. (SNGXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-02-03 | Phio Pharmaceuticals Corp. (RXIIW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-20 | — | Grant (A) | — | $0 | |
| 2016-02-12 | Phio Pharmaceuticals Corp. (RXII) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-19 | — | Grant (A) | — | $0 | |
| 2015-06-02 | Phio Pharmaceuticals Corp. (RXII) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-04-09 | — | Exer (M) | +14,286 | $8.7K | |
| 2013-10-15 | Vyant Bio, Inc. (CGIX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.